Ondine Biomedical Inc. (OBI.L)
GBp 9.0
(0.0%)
GBp 9.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.41 Million CAD | 30.66% |
| 2022 | -20.78 Million CAD | 74.9% |
| 2021 | -82.81 Million CAD | -389.54% |
| 2020 | -16.91 Million CAD | -19.44% |
| 2019 | -14.16 Million CAD | 14.96% |
| 2018 | -16.65 Million CAD | -158.87% |
| 2017 | -6.43 Million CAD | 0.0% |
| 2010 | -3.25 Million CAD | 29.13% |
| 2009 | -4.59 Million CAD | 55.25% |
| 2008 | -10.26 Million CAD | 21.93% |
| 2007 | -13.15 Million CAD | -9.96% |
| 2006 | -11.96 Million CAD | -40.1% |
| 2005 | -8.53 Million CAD | 0.0% |
| 2003 | -84.34 Thousand CAD | 94.51% |
| 2002 | -1.53 Million CAD | -1997.81% |
| 2001 | -73.29 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -4.51 Million GBP | 0.0% |
| 2023 Q2 | -4.75 Million GBP | 0.0% |
| 2023 Q4 | -3.84 Million GBP | 0.0% |
| 2023 FY | -14.41 Million CAD | 30.66% |
| 2022 FY | -20.78 Million CAD | 74.9% |
| 2022 Q2 | -5.19 Million GBP | 0.0% |
| 2022 Q4 | -6.9 Million GBP | 0.0% |
| 2021 FY | -82.81 Million CAD | -389.54% |
| 2020 FY | -16.91 Million CAD | -19.44% |
| 2019 FY | -14.16 Million CAD | 14.96% |
| 2018 FY | -16.65 Million CAD | -158.87% |
| 2017 FY | -6.43 Million CAD | 0.0% |
| 2011 Q1 | -1 Million CAD | -46.06% |
| 2011 Q2 | -1.19 Million CAD | -18.92% |
| 2010 Q2 | -1.07 Million CAD | 5.69% |
| 2010 FY | -3.25 Million CAD | 29.13% |
| 2010 Q1 | -1.13 Million CAD | 7.2% |
| 2010 Q4 | -690.81 Thousand CAD | -119.03% |
| 2010 Q3 | -315.4 Thousand CAD | 70.61% |
| 2009 Q4 | -1.22 Million CAD | 22.48% |
| 2009 FY | -4.59 Million CAD | 55.25% |
| 2009 Q1 | -1.44 Million CAD | 31.88% |
| 2009 Q2 | -340.9 Thousand CAD | 76.43% |
| 2009 Q3 | -1.58 Million CAD | -364.06% |
| 2008 Q1 | -2.46 Million CAD | 9.77% |
| 2008 FY | -10.26 Million CAD | 21.93% |
| 2008 Q3 | -3.25 Million CAD | -33.68% |
| 2008 Q4 | -2.12 Million CAD | 34.7% |
| 2008 Q2 | -2.43 Million CAD | 1.25% |
| 2007 Q3 | -3.18 Million CAD | 16.0% |
| 2007 FY | -13.15 Million CAD | -9.96% |
| 2007 Q4 | -2.72 Million CAD | 14.24% |
| 2007 Q1 | -3.45 Million CAD | 0.35% |
| 2007 Q2 | -3.78 Million CAD | -9.77% |
| 2006 Q3 | -2.78 Million CAD | 3.18% |
| 2006 FY | -11.96 Million CAD | -40.1% |
| 2006 Q4 | -3.46 Million CAD | -24.42% |
| 2006 Q2 | -2.87 Million CAD | -1.32% |
| 2006 Q1 | -2.83 Million CAD | -21.34% |
| 2005 FY | -8.53 Million CAD | 0.0% |
| 2005 Q1 | -1.78 Million CAD | -182.45% |
| 2005 Q2 | -2.3 Million CAD | -29.42% |
| 2005 Q3 | -2.11 Million CAD | 8.19% |
| 2005 Q4 | -2.33 Million CAD | -10.59% |
| 2004 Q3 | -1.53 Million CAD | -20.09% |
| 2004 Q4 | -630.31 Thousand CAD | 58.83% |
| 2004 Q2 | -1.27 Million CAD | 28.16% |
| 2004 Q1 | -1.77 Million CAD | -3708.53% |
| 2003 FY | -84.34 Thousand CAD | 94.51% |
| 2003 Q1 | -20.72 Thousand CAD | -854.33% |
| 2003 Q4 | -46.6 Thousand CAD | -35.78% |
| 2003 Q3 | -34.32 Thousand CAD | -26.53% |
| 2003 Q2 | -27.12 Thousand CAD | -30.85% |
| 2002 Q1 | -14.14 Thousand CAD | 41.19% |
| 2002 Q3 | -1.47 Million CAD | -6191.89% |
| 2002 Q4 | -2172.00 CAD | 99.85% |
| 2002 FY | -1.53 Million CAD | -1997.81% |
| 2002 Q2 | -23.45 Thousand CAD | -65.81% |
| 2001 Q4 | -24.05 Thousand CAD | 0.0% |
| 2001 FY | -73.29 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|